Regenerative Medicine Approach
Our clinical practice offers an integral functional regenerative medicine therapy for Multiple Sclerosis (MS), utilizing umbilical cord mesenchymal stem cells as the core therapeutic component. This approach is systematically supported by targeted physical therapy and evidence-based nutritional medicine protocols to address the complex pathophysiology of autoimmune demyelinating disease and immune dysregulation.
Our therapeutic strategy for Multiple Sclerosis combines cellular regenerative approaches with functional rehabilitation and metabolic optimization to address the multifactorial nature of autoimmune demyelinating disease.
The foundation of our approach involves the precise intravenous and, when clinically indicated, targeted administration of umbilical cord-derived mesenchymal stem cells (UC-MSCs). These cells are selected for their documented immunomodulatory and neuroprotective properties and potential to modulate autoimmune responses and support remyelination associated with Multiple Sclerosis. Administration is performed under strict clinical protocols to ensure patient safety and accurate delivery.
Following cellular administration, patients engage in a structured neurorehabilitation program specifically designed for MS. This program integrates progressive physical therapy protocols that address mobility, balance, spasticity, and fatigue management. The rehabilitation component is individually calibrated based on the extent of neurological involvement, disease course (relapsing-remitting, primary progressive, secondary progressive), and the patient's functional baseline.
Clinical visualization: Immune modulation and remyelination in Multiple Sclerosis
Umbilical cord mesenchymal stem cells are utilized for their potential to modulate inflammatory cascades associated with autoimmune demyelination and support neuroprotection and repair of neural tissue. Cellular processing follows established laboratory protocols with documented quality control measures.
Learn MoreA graduated neurorehabilitation program is implemented to optimize functional outcomes while managing MS‑related fatigue and neurological deficits. This includes gait training, balance exercises, spasticity management, and cognitive rehabilitation, all timed to coincide with expected phases of cellular integration and immune modulation.
Learn MoreEvidence-based nutritional protocols are provided to support myelin integrity, mitochondrial function, and reduction of oxidative stress. These recommendations address nutritional factors that may influence autoimmune activity, and the metabolic environment for neurological recovery.
Learn MoreMultiple Sclerosis represents a complex autoimmune condition involving demyelination and neurodegeneration within the central nervous system. The integration of cellular therapy with structured rehabilitation acknowledges the persistent inflammatory and autoimmune components that drive disease progression. The therapeutic objective extends beyond cellular administration to creating an optimal environment for immunomodulation, neuroprotection, and subsequent functional improvement.
"In clinical management of Multiple Sclerosis, consideration must be given to both the biological aspects of immune dysregulation and the functional deficits experienced by patients. The regenerative medicine approach we employ seeks to address these dual considerations through a coordinated therapeutic strategy. This integrated methodology represents a logical progression in the comprehensive management of autoimmune demyelinating disease."
Medical illustration: Demyelination and axonal damage in Multiple Sclerosis
Histological visualization: Inflammatory infiltrates and demyelinated plaques in MS
Multiple Sclerosis involves complex changes in immune function, inflammatory signaling, and neural integrity. Autoimmune‑mediated demyelination, axonal loss, and gliosis are key pathological features. Degenerative and inflammatory processes disrupt normal neural transmission, leading to a wide range of symptoms including motor, sensory, visual, and cognitive impairment.
The regenerative approach we employ considers these pathophysiological aspects by addressing multiple components of the autoimmune cascade. Cellular therapy aims to modulate local and systemic inflammatory environments while potentially supporting remyelination and neuroprotection. Concurrent rehabilitation strategies address the functional aspects of recovery, and nutritional support targets metabolic factors that may influence neurological health.
Our evaluation protocol includes comprehensive assessment of MS disease course, disability status (EDSS), functional limitations, and individual patient factors to determine appropriateness for regenerative medicine intervention. This process involves detailed review of clinical history, MRI imaging, and functional assessment.
Initiate Clinical Evaluation